Treating Eating Disorder Clients Amid the GLP-1 Craze: A Complex Landscape
By Dr. Sophianne Schwab, Medical Director at Skyway Behavioral Health The rise of GLP-1 medications like Ozempic and Wegovy has ignited significant debate, particularly among